| Literature DB >> 35878230 |
Yulei Zhang1,2, Jieyi Li1, Zhangxi Hu1,2, Dong Chen1, Feng Li1,2, Xianghu Huang1,2, Changling Li1,2.
Abstract
It is widely accepted that eutrophication has played an important role in the formation of harmful cyanobacterial blooms in recent decades, which impacts water quality and ecological environment and causes huge economic losses. Algicidal bacteria have a promising application prospect in controlling cyanobacterial blooms in aquaculture water. Here, the process of the algicidal bacterium Brevibacillus laterosporus strain Bl-zj acting on Microcystis aeruginosa was explored using transcriptome analysis to elucidate the algicidal mechanism. The results of the co-culture of bacterium and alga showed a strong alga-lysing effect of B. laterosporus against M. aeruginosa with an extreme morphology deformation of the algal cells. A total of 2744 differentially expressed genes of B. laterosporus were identified, which were mainly involved in the metabolism of amino acid, carbohydrate, and lipid. In the co-cultured group, the expression of genes mainly enriched in valine, leucine and isoleucine degradation, and fatty acid degradation were significantly increased. However, the expression of the genes related to ribosome were mainly inhibited. Transcriptome analysis showed that B. laterosporus obtained ATP and energy by the degradation of valine, leucine, isoleucine, and fatty acids, and destroyed algal cells by efflux pump transporters, secretion of hydrolytic enzymes, antibiotics, proteases, and other secondary metabolites, resulting in algal death and achieving the algicidal effect.Entities:
Keywords: Brevibacillus laterosporus; Microcystis aeruginosa; algicidal effect; degradation; hydrolase; transcriptome; transporter
Mesh:
Substances:
Year: 2022 PMID: 35878230 PMCID: PMC9320710 DOI: 10.3390/toxins14070492
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Figure 1Morphology of M. aeruginosa (A), M. aeruginosa co-cultured with B. laterosporus for 1 d (B), 2 d (C), 3 d (D), and 4 d (E) by scanning electron microscopy (Scale bars = 2 μm). The red arrows showed the antenna-like mucus or cell depression and deformation.
Overview of B. laterosporus transcriptome sequencing data.
| Sample | Raw Data (bp) | Raw Reads No. | Clean Data (bp) | Clean Reads No. | Mapped Reads No. | Q20 (%) | Q30 (%) |
|---|---|---|---|---|---|---|---|
| CBL1 | 8,378,192,100 | 55,854,614 | 7,357,141,200 | 49,047,608 | 48,325,154 | 98.14 | 94.54 |
| CBL2 | 8,746,394,400 | 58,309,296 | 7,617,902,100 | 50,786,014 | 49,954,121 | 98.07 | 94.42 |
| CBL3 | 7,970,677,500 | 53,137,850 | 7,125,755,100 | 47,505,034 | 46,792,179 | 98.05 | 94.30 |
| MB2_1 | 11,260,710,900 | 75,071,406 | 9,110,216,700 | 60,734,778 | 15,744,400 | 97.73 | 94.22 |
| MB2_2 | 9,961,599,300 | 66,410,662 | 7,954,650,900 | 53,031,006 | 12,159,967 | 97.62 | 93.88 |
| MB2_3 | 9,498,113,100 | 63,320,754 | 7,660,962,000 | 51,073,080 | 12,936,077 | 97.65 | 93.90 |
| MB4_1 | 10,501,108,500 | 70,007,390 | 8,108,475,900 | 54,056,506 | 15,140,888 | 97.72 | 94.15 |
| MB4_2 | 9,475,501,500 | 63,170,010 | 7,402,896,600 | 49,352,644 | 42,864,396 | 97.29 | 93.41 |
| MB4_3 | 9,642,770,100 | 64,285,134 | 7,021,052,700 | 46,807,018 | 13,102,733 | 96.94 | 92.90 |
| Average | 9,492,785,267 | 63,285,235 | 7,706,561,467 | 51,377,076 | 28,557,768 | 97.69 | 93.97 |
Figure 2The principal component analysis (PCA) of each sample. The blue, red and green labels represent the treatment group of CBL, MB2 and MB4, respectively. The circle, triangle and square labels represent replication 1, replication 2 and replication 3 samples in each group, respectively.
Figure 3The number of differentially expressed genes (DEGs) at MB2 and MB4 groups compared with CBL group. “↑” and “↓” represent up- and down-regulated genes, respectively.
Figure 4Gene ontology (GO) enrichment analysis of the differently expressed genes at two groups compared with CBL group. (a) MB2 vs. CBL comparison, (b) MB4 vs. CBL comparison.
Distribution of up- and down-regulated genes in KEGG pathways.
| Level 2 | MB2 vs. CBL | MB4 vs. CBL | ||||
|---|---|---|---|---|---|---|
| Up | Down | Total | Up | Down | Total | |
| Amino acid metabolism | 122 | 47 | 169 | 131 | 76 | 207 |
| Carbohydrate metabolism | 93 | 90 | 183 | 93 | 116 | 209 |
| Lipid metabolism | 51 | 15 | 66 | 52 | 22 | 74 |
| Metabolism of cofactors and vitamins | 28 | 36 | 64 | 26 | 41 | 67 |
| Energy metabolism | 34 | 16 | 40 | 32 | 21 | 53 |
| Nucleotide metabolism | 6 | 32 | 38 | 7 | 43 | 50 |
| Translation | 0 | 33 | 33 | 1 | 47 | 48 |
| Xenobiotics biodegradation and metabolism | 24 | 14 | 38 | 24 | 21 | 45 |
| Membrane transport | 13 | 21 | 34 | 13 | 28 | 41 |
| Metabolism of other amino acids | 18 | 9 | 27 | 13 | 16 | 29 |
| Replication and repair | 1 | 9 | 10 | 7 | 14 | 21 |
| Folding, sorting and degradation | 4 | 10 | 14 | 6 | 13 | 19 |
| Biosynthesis of other secondary metabolites | 11 | 5 | 16 | 10 | 7 | 17 |
| Metabolism of terpenoids and polyketides | 11 | 4 | 15 | 11 | 6 | 17 |
| Cellular community—prokaryotes | 4 | 5 | 9 | 6 | 6 | 12 |
| Infectious diseases: Bacterial | 1 | 3 | 4 | 2 | 2 | 4 |
| Signal transduction | 3 | 0 | 3 | 3 | 1 | 4 |
| Immune system | 1 | 1 | 2 | 1 | 1 | 2 |
| Transcription | 0 | 1 | 1 | 0 | 2 | 2 |
| Environmental adaptation | 1 | 0 | 1 | 1 | 0 | 1 |
| Cell growth and death | 0 | 0 | 0 | 0 | 3 | 3 |
| Glycan biosynthesis and metabolism | 1 | 0 | 1 | 0 | 0 | 0 |
Figure 5KEGG pathway enrichment analysis. (a) MB2 vs. CBL comparison, (b) MB4 vs. CBL comparison.
Figure 6Pathways of valine, leucine, isoleucine and fatty acids degradation. (Red and green represent up-regulated and down-regulated genes, respectively.)
DEGs related to transporters.
| Gene ID | MB2 vs. CBL | MB4 vs. CBL | Description | ||
|---|---|---|---|---|---|
| log2 (Fold Change) | log2 (Fold Change) | ||||
| gene2217 | 7.04 | 1.04 × 10−17 | 2.29 | 1.80 × 10−11 | ABC transporter |
| gene3791 | 3.08 | 1.12 × 10−3 | 2.09 | 1.31 × 10−3 | ABC transporter family protein |
| gene2788 | 3.56 | 2.60 × 10−5 | 1.68 | 1.13 × 10−8 | ABC transporter family protein |
| gene4041 | 7.42 | 1.34 × 10−8 | 1.96 | 1.33 × 10−2 | ABC transporter permease protein |
| gene2787 | 3.40 | 7.31 × 10−6 | 1.63 | 2.79 × 10−2 | ABC transporter permease protein |
| gene0214 | 3.53 | 1.37 × 10−5 | 5.08 | 6.01 × 10−14 | ABC transporter permease protein |
| gene3837 | 4.19 | 2.00 × 10−15 | 1.48 | 1.64 × 10−3 | ABC transporter ATP-binding/permease protein |
| gene3838 | 4.42 | 1.73 × 10−7 | 2.33 | 2.00 × 10−3 | ABC transporter ATP binding/permease protein |
| gene3493 | 2.68 | 7.63 × 10−6 | 6.01 | 2.16 × 10−4 | ABC transporter substrate-binding protein |
| gene2004 | 3.42 | 2.74 × 10−7 | 3.01 | 1.19 × 10−20 | ABC transporter ATP-binding protein |
| gene1946 | 2.47 | 5.55 × 10−6 | 4.62 | 3.49 × 10−23 | ABC-2 type transporter family protein |
| gene1947 | 2.15 | 5.42 × 10−6 | 3.01 | 3.80 × 10−22 | Putative ABC transporter ATP-binding protein |
| gene0517 | 6.50 | 9.88 × 10−9 | 1.12 | 1.45 × 10−2 | Oligopeptide/dipeptide ABC transporter, ATP-binding, C-terminal domain protein |
| gene0714 | 2.15 | 1.09 × 10−2 | 1.45 | 1.66 × 10−2 | Peptide permease, major facilitator family transporter |
| gene1164 | 7.78 | 2.54 × 10−41 | 5.61 | 1.46 × 10−57 | Oligopeptide transporter, OPT family |
| gene2954 | 3.43 | 4.50 × 10−3 | 2.82 | 1.82 × 10−6 | Putative bacteriocin export ABC transporter, lactococcin group |
| gene3098 | 3.31 | 1.67 × 10−10 | 1.85 | 4.72 × 10−6 | Cyclic peptide transporter family protein |
| gene1210 | 1.83 | 3.92 × 10−3 | 4.71 | 5.95 × 10−43 | Uncharacterized MFS-type transporter |
| gene1223 | 3.71 | 3.11 × 10−8 | 3.23 | 1.02 × 10−24 | Glycerol-3-phosphate transporter |
| gene1160 | 1.33 | 5.63 × 10−3 | – | – | Putative multidrug resistance ABC transporter ATP-binding/permease protein |
| gene1161 | 1.60 | 1.44 × 10−2 | – | – | Putative multidrug resistance ABC transporter ATP-binding/permease protein |
| gene1174 | 1.12 | 4.87 × 10−2 | – | – | ABC transporter family protein |
| gene1714 | 2.70 | 4.84 × 10−2 | – | – | Phosphate ABC transporter, permease protein |
| gene0216 | 3.44 | 2.08 × 10−2 | – | – | ABC transporter substrate binding protein |
| gene3053 | 1.05 | 2.63 × 10−2 | – | – | Oligopeptide ABC transporter permease protein |
| gene3055 | 1.74 | 2.24 × 10−2 | – | – | Oligopeptide ABC transporter ATP binding protein |
| gene3056 | 1.39 | 3.32 × 10−2 | – | – | Oligopeptide ABC transporter ATP binding protein |
| gene0492 | 1.89 | 1.72 × 10−3 | – | – | Citrate transporter family protein |
| gene1184 | – | – | 6.92 | 2.76 × 10−44 | Inner membrane transporter |
| gene2438 | – | – | 5.09 | 9.13 × 10−12 | Proton-coupled thiamine transporter |
| gene2761 | – | – | 1.85 | 4.33 × 10−10 | Formate/nitrite transporter |
| gene3336 | – | – | 5.41 | 1.44 × 10−5 | Efflux transporter, RND family, MFP subunit |
| gene4037 | – | – | 1.41 | 1.03 × 10−2 | ABC transporter family protein |
DEGs related to hydrolase.
| Gene ID | MB2 vs. CBL | MB4 vs. CBL | Description | ||
|---|---|---|---|---|---|
| log2 (FoldChange) | log2 (FoldChange) | ||||
| gene2281 | 1.47 | 4.43 × 10−3 | 1.54 | 1.24 × 10−6 | Cof-like hydrolase family protein |
| gene2308 | 10.39 | 1.83 × 10−9 | 8.98 | 6.29 × 10−27 | Cell wall hydrolase |
| gene2656 | 2.72 | 7.69 × 10−5 | 3.27 | 2.63 × 10−13 | Dienelactone hydrolase family protein |
| gene2741 | 1.97 | 8.71 × 10−4 | 1.18 | 6.71 × 10−3 | Putative hydrolase |
| gene2775 | 1.30 | 2.05 × 10−2 | 1.87 | 3.04 × 10−7 | HAD-superfamily hydrolase |
| gene3428 | 5.31 | 5.85 × 10−5 | 4.89 | 7.79 × 10−8 | Glycoside hydrolase, family 18 |
| gene3564 | 2.65 | 4.09 × 10−4 | 4.51 | 1.49 × 10−34 | Putative polyketide biosynthesis zinc-dependent hydrolase |
| gene3616 | 2.37 | 4.74 × 10−4 | 1.71 | 1.30 × 10−4 | Alpha/beta hydrolase fold family protein |
| gene3797 | 4.40 | 8.05 × 10−12 | 3.60 | 2.13 × 10−12 | Amidohydrolase family protein |
| gene0510 | 4.40 | 9.63 × 10−17 | 4.25 | 3.45 × 10−33 | Fumarylacetoacetate (FAA) hydrolase family protein |
| gene0800 | 4.04 | 1.44 × 10−2 | 6.09 | 2.09 × 10−4 | Glycosyl hydrolase |
| gene1702 | 2.73 | 9.47 × 10−6 | 4.61 | 2.82 × 10−25 | Metal dependent phosphohydrolase |
| gene1917 | 3.10 | 3.78 × 10−5 | 5.27 | 7.59 × 10−48 | Membrane-bound metal-dependent hydrolase |
| gene2086 | 1.21 | 3.56 × 10−2 | 1.25 | 3.42 × 10−4 | Alpha/beta hydrolase fold family protein |
| gene2140 | 2.10 | 3.17 × 10−2 | 1.09 | 2.07 × 10−3 | Amylopullulanase |
| gene3978 | 3.62 | 6.60 × 10−4 | 2.59 | 5.05 × 10−16 | Chitinase A1 |
| gene0479 | 3.74 | 1.88 × 10−8 | 3.48 | 1.75 × 10−5 | Peptidase M23 family protein |
| gene1871 | 7.77 | 1.15 × 10−17 | 8.58 | 5.53 × 10−18 | Peptidase M23 family protein |
| gene3430 | 5.06 | 9.12 × 10−7 | 3.75 | 1.63 × 10−7 | Peptidase M23/M37 family protein |
| gene0291 | 5.00 | 2.48 × 10−5 | 3.73 | 7.53 × 10−6 | Peptidase M20 family protein |
| gene1081 | 5.98 | 8.93 × 10−17 | 4.50 | 2.08 × 10−3 | Minor extracellular protease |
| gene2099 | 2.44 | 1.79 × 10−6 | 2.32 | 2.70 × 10−12 | Intracellular protease |
| gene0588 | 7.01 | 5.70 × 10−5 | 5.26 | 2.53 × 10−17 | Serine protease |
| gene2096 | 4.37 | 7.44 × 10−3 | – | – | Alpha/beta hydrolase fold family protein |
| gene1396 | 1.12 | 3.49 × 10−2 | – | – | Peptidyl-tRNA hydrolase |
| gene2293 | 2.27 | 3.88 × 10−3 | – | – | Oligoendopeptidase F |
| gene2996 | 1.52 | 1.58 × 10−2 | – | – | Peptidase SpoIVB |
| gene2763 | 1.60 | 7.96 × 10−4 | – | – | Metalloprotease YpwA |
| gene1264 | – | – | 4.10 | 1.38 × 10−2 | Acetyltransferases and hydrolases with the alpha/beta hydrolase fold |
| gene1950 | – | – | 1.70 | 9.00 × 10−5 | |
| gene1974 | – | – | 1.63 | 9.93 × 10−4 | Glycoside hydrolase family 18 |
DEGs related to biosynthesis of other secondary metabolites.
| Gene ID | MB2 vs. CBL | MB4 vs. CBL | Description | ||
|---|---|---|---|---|---|
| log2(Fold Change) | log2(Fold Change) | ||||
| Novobiocin biosynthesis | |||||
| gene3280 | 2.01 | 1.82 × 10−2 | 1.18 | 1.39 × 10−3 | Histidinol-phosphate aminotransferase |
| gene3516 | −4.17 | 7.39 × 10−18 | −2.84 | 9.13 × 10−17 | Threonine-phosphate decarboxylase |
| Prodigiosin biosynthesis | |||||
| gene3924 | 4.36 | 6.65 × 10−7 | 3.83 | 1.70 × 10−6 | Short chain dehydrogenase family protein |
| gene1867 | 5.08 | 9.86 × 10−14 | 4.62 | 2.10 × 10−30 | 3-oxoacyl-[acyl-carrier-protein] reductase |
| gene3734 | 6.01 | 4.80 × 10−11 | 4.52 | 7.65 × 10−20 | Malonyl CoA-acyl carrier protein transacylase |
| gene3394 | 6.55 | 2.29 × 10−33 | 5.96 | 6.87 × 10−66 | Malonyl CoA-acyl carrier protein transacylase |
| gene4412 | 1.37 | 6.10 × 10−3 | – | – | Putative 3-oxoacyl-[acyl-carrier protein] reductase |
| gene4621 | −2.01 | 8.40 × 10−6 | −3.57 | 8.84 × 10−25 | 3-oxoacyl-[acyl-carrier-protein] reductase |
| gene4622 | −2.30 | 3.87 × 10−7 | −3.55 | 5.31 × 10−25 | Malonyl CoA-acyl carrier protein transacylase |
| gene2031 | – | – | −2.14 | 2.97 × 10−10 | Enoyl-[acyl-carrier-protein] reductase |
| gene3922 | – | – | −1.85 | 4.54 × 10−5 | Malonyl CoA-acyl carrier protein transacylase |
| Acarbose and validamycin biosynthesis | |||||
| gene1620 | 3.30 | 8.16 × 10−3 | 2.25 | 4.18 × 10−4 | CDP-glucose 4,6-dehydratase |
| Streptomycin biosynthesis | |||||
| gene1620 | 3.30 | 8.16 × 10−3 | 2.25 | 4.18 × 10−4 | CDP-glucose 4,6-dehydratase |
| gene3643 | 2.42 | 4.89 × 10−5 | – | – | Myo-inositol-1-phosphate synthase family protein |
| gene0637 | – | – | 1.81 | 9.29 × 10−7 | Inositol monophosphatase family protein |
| Monobactam biosynthesis | |||||
| gene2420 | 1.97 | 1.33 × 10−3 | 1.75 | 1.95 × 10−5 | Aspartokinase 2 |
| gene2342 | 2.41 | 1.91 × 10−5 | – | – | Sulfate adenylyltransferase |
| gene3298 | −1.43 | 4.14 × 10−3 | – | – | Dihydrodipicolinate reductase |
| Carbapenem biosynthesis | |||||
| gene0853 | −1.04 | 3.28 × 10−2 | −1.09 | 7.42 × 10−3 | Glutamate-5-semialdehyde dehydrogenase |
| gene0853 | – | – | −1.75 | 1.93 × 10−7 | Glutamate-5-semialdehyde dehydrogenase |
| Phenazine biosynthesis | |||||
| gene3274 | – | – | 5.34 | 7.17 × 10−9 | Anthranilate synthase component |
Figure 7Comparison of the expressions of nine DEGs determined by Illumina HiSeq 2500 sequencing and qRT-PCR (The qRT-PCR data of up-regulated genes were redrawn from Zhang et al., 2021 [15]). (a) MB2 vs. CBL comparison, (b) MB4 vs. CBL comparison.